Lupus is an urgent National Health problem affecting at least 1.5 million Americans yet existing treatments are inadequate.  Many are toxic, suppress the entire immune system, and cause detrimental side effects over time.  There are only 4 drugs approved for lupus so most treatments being used are borrowed from other diseases like Cancer.  It is a costly multi-system disease as patients must regularly see several specialists and it can affect virtually any part of the body including vital organs making it the prototypical autoimmune disease.  The benefits of lupus research could be promising for over 100 other autoimmune disorders, yet present funding for lupus research remains insufficient.  Every member of the lupus community must join together to support increased research funding that will enable scientists to find the cause, develop precise diagnostic measures, discover safer, more effective treatments, and ultimately find the cure. 

ANNUAL RESEARCH DONATION


Lupus Research Institute Chairmen Jack Lavery
(left) and Robert Ravitz (right) receive our largest
ever Research Donation of $24,000.  This gift 
represents 1/3 of our annual income for 2010 from
Lupus Foundation of Mid and NNY President/CEO
Kathleen Arntsen on October 18th at the LRI
Annual Scientific Meeting at the New York Marriott
Marquis.  We have now donated $151,500 for
lupus research to the LRI in the past 9 years.

 

Lupus Foundation of Mid and Northern New York
President/CEO Kathleen Arntsen with Dr. Steven Katz, 
Director of NIAMS and LFMNNY Volunteer
Jackie Taylor at the October 2008 LRI Annual
Scientific Meeting at the Yale Club in New York City

"Hope is on the Horizon" Education Symposium Materials
Participating in Clinical Trials

LRI National Coalition Clinical Trials Website
www.lupustrials.org

Clinical Trial Information on Lupus 
http://www.clinicaltrials.gov/ct/search?term=lupus+&submit=Search        

LRI Patient Resource Guide for Clinical Trials